The irradiation tolerance dose of the proximal vagina

Radiotherapy and Oncology

Volumn 67, Issue 1, 2003, Pages 77-85

  Au, Samuel P ^a   Grigsby, Perry W ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Radiation Oncology Center   (United States)

Author keywords

Brachytherapy; Dose; Irradiation; Tolerance; Vagina

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; TREATMENT OUTCOME; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA; VAGINA MUCOSA;

EID: 0038368750     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(02)00384-5     Document Type: Article

References (32)

1. Abitbol A.A., Wolfson A.H., Lewin A.A., et al. Management of stage I-B, II-A, and II-B carcinoma of the cervix with high-dose-rate brachytherapy: initial results of an institutional clinical trial. Am J Clin Oncol. 19:1996;223-228.
2. Chatani M., Matayoshi Y., Masaki N., Teshima T., Inoue T. A prospective randomized study concerning the point A dose in high-dose rate intracavitary therapy for carcinoma of the uterine cervix. The final results. Strahlenther Onkol. 170:1994;636-642.
3. Deore S.M., Shrivastava S.K., Supe S.J., Viswanathan P.S., Dinshaw K.A. Alpha/beta value and importance of dose per fraction for the late rectal and recto-sigmoid complications. Strahlenther Onkol. 169:1993;521-526.
4. Eifel P.J., Thoms W.W. Jr., Smith T.L., Morris M., Oswald M.J. The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone. Int J Radiat Oncol Biol Phys. 28:1994;113-118.
5. Fowler J.F. Dose reduction factors when increasing dose rate in LDR or MDR brachytherapy of carcinoma of the cervix. Radiother Oncol. 45:1997;49-54.
6. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 62:1989;679-694.
7. Fowler J.F., Denekamp J., Thames H.D., Travis E.L. Repair factors for multifraction irradiations. Radiother Oncol. 1:1984;281-286.
8. Fowler J.F., Shuttleworth E. Fractionation and biological equivalence. Br J Radiol. 39:1966;958.
9. Haie-Meder C., Kramar A., Lambin P., et al. Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. Int J Radiat Oncol Biol Phys. 29:1994;953-960.
10. Hintz B.L., Kagan A.R., Chan P., et al. Radiation tolerance of the vaginal mucosa. Int J Radiat Oncol Biol Phys. 6:1980;711-716.
11. Kato E., Morita K. Treatment results of conformation radiotherapy for stage I and II cervical cancer. Nippon Igaku Hoshasen Gakkai Zasshi. 55:1995;240-246.
12. Kuske R.R., Perez C.A., Jacobs A.J., et al. Mini-colpostats in the treatment of carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 14:1988;899-906.
13. Lambin P., Gerbaulet A., Kramar A., et al. Phase III trial comparing two low dose rates in brachytherapy of cervix carcinoma: report at two years. Int J Radiat Oncol Biol Phys. 25:1993;405-412.
14. Lancar R., Kramar A., Haie-Meder C., et al. Method for evaluating long term complications. A study from a phase III trial comparing two low dose rates in gynecologic brachytherapy. Bull Cancer. 81:1994;632-637.
15. Leborgne F., Fowler J.F., Leborgne J.H., Zubizarreta E., Curochquin R. Medium-dose-rate brachytherapy of cancer of the cervix: preliminary results of a prospectively designed schedule based on the linear-quadratic model. Int J Radiat Oncol Biol Phys. 43:1999;1061-1064.
16. Muramoto H., Obata Y. Experience and results of application of a remote afterloading system (RALS) optimization program for intracavitary treatment of squamous cell carcinoma of the uterine cervix. Nippon Igaku Hoshasen Gakkai Zasshi. 54:1994;264-268.
17. Noyes W.R., Peters N.E., Thomadsen B.R., et al. Impact of 'optimized' treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 31:1995;79-86.
18. Orton C.G. Fractionation is important for HDR cervix cancer brachytherapy. Int J Radiat Oncol Biol Phys. 22:1992;222-223.
19. Orton C.G. High and low dose-rate brachytherapy for cervical carcinoma. Acta Oncol. 37:1998;117-125.
20. Orton C.G. Width of the therapeutic window: what is the optimal dose-per-fraction for high dose rate cervix cancer brachytherapy? Int J Radiat Oncol Biol Phys. 31:1995;1011-1013.
21. Orton C.G., Seyedsadr M., Somnay A. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys. 21:1991;1425-1434.
22. Orton C.G., Wolf-Rosenblum S. Dose dependence of complication rates in cervix cancer radiotherapy. Int J Radiat Oncol Biol Phys. 12:1986;37-44.
23. Paris K.J., Spanos W.J. Jr., Day T.G. Jr., Jose B., Lindberg R.D. Incidence of complications with mini vaginal colpostats in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 21:1991;911-917.
24. Patel F.D., Sharma S.C., Negi P.S., Ghoshal S., Gupta B.D. Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial. Int J Radiat Oncol Biol Phys. 28:1994;335-341.
25. Perez C.A., Breaux S., Bedwinek J.M., et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications. Cancer. 54:1984;235-246.
26. Petereit D.G., Fowler J.F., Kinsella T.J. Optimizing the dose rate and technique in cervical carcinoma - balancing cases versus complications (editorial; comment). Int J Radiat Oncol Biol Phys. 29:1994;1195-1197.
27. Rasovska O., Tacev T., Ptackova B., Strnad V. Complications of radiotherapy of uterine cervix carcinoma. Radiobiol Radiother. 31:1990;85-91.
28. Rodrigus P., De Winter K., Venselaar J.L., Leers W.H. Evaluation of late morbidity in patients with carcinoma of the uterine cervix following a dose rate change. Radiother Oncol. 42:1997;137-141.
29. Sarkaria J.N., Petereit D.G., Stitt J.A., et al. A comparison of the efficacy and complication rates of low dose-rate versus high dose-rate brachytherapy in the treatment of uterine cervical carcinoma. Int J Radiat Oncol Biol Phys. 30:1994;75-82.
30. Teshima T., Inoue T., Ikeda H., et al. High-dose rate intracavitary therapy for cervical cancer with a microSelectron: a preliminary report. Radiat Med. 11:1993;237-241.
31. Toita T., Kakinohana Y., Shinzato S., et al. Tumor diameter/volume and pelvic node status assessed by magnetic resonance imaging (MRI) for uterine cervical cancer treated with irradiation. Int J Radiat Oncol Biol Phys. 43:1999;777-782.
32. Visser P.A., Moonen L.M., van der Kogel A.J., Keijser A.H. Application of the linear-quadratic-concept for prediction of late complications after combined irradiation of the uterine cervix. Radiother Oncol. 4:1985;133-141.